newsfilter
← Latest News
GlobeNewswire·

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA, Dec. 29, 2023 -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (NASDAQ:CYTO), a company providing nanoparticle-based